Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Neurovascular and neuroimmune aspects in the pathophysiology of rosacea.

Schwab VD, Sulk M, Seeliger S, Nowak P, Aubert J, Mess C, Rivier M, Carlavan I, Rossio P, Metze D, Buddenkotte J, Cevikbas F, Voegel JJ, Steinhoff M.

J Investig Dermatol Symp Proc. 2011 Dec;15(1):53-62. doi: 10.1038/jidsymp.2011.6.

2.

Neurovascular aspects of skin neurogenic inflammation.

Aubdool AA, Brain SD.

J Investig Dermatol Symp Proc. 2011 Dec;15(1):33-9. doi: 10.1038/jidsymp.2011.8. Review.

3.

Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.

Steinhoff M, Buddenkotte J, Aubert J, Sulk M, Novak P, Schwab VD, Mess C, Cevikbas F, Rivier M, Carlavan I, Déret S, Rosignoli C, Metze D, Luger TA, Voegel JJ.

J Investig Dermatol Symp Proc. 2011 Dec;15(1):2-11. doi: 10.1038/jidsymp.2011.7. Review.

4.

TRPV3 regulates nitric oxide synthase-independent nitric oxide synthesis in the skin.

Miyamoto T, Petrus MJ, Dubin AE, Patapoutian A.

Nat Commun. 2011 Jun 28;2:369. doi: 10.1038/ncomms1371.

5.

TRPV4 mediates tumor-derived endothelial cell migration via arachidonic acid-activated actin remodeling.

Fiorio Pla A, Ong HL, Cheng KT, Brossa A, Bussolati B, Lockwich T, Paria B, Munaron L, Ambudkar IS.

Oncogene. 2012 Jan 12;31(2):200-12. doi: 10.1038/onc.2011.231.

PMID:
21685934
6.

Mast-cell degranulation induced by physical stimuli involves the activation of transient-receptor-potential channel TRPV2.

Zhang D, Spielmann A, Wang L, Ding G, Huang F, Gu Q, Schwarz W.

Physiol Res. 2012;61(1):113-24.

7.

Interventions for rosacea.

van Zuuren EJ, Kramer S, Carter B, Graber MA, Fedorowicz Z.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD003262. doi: 10.1002/14651858.CD003262.pub4. Review. Update in: Cochrane Database Syst Rev. 2015;4:CD003262.

PMID:
21412882
8.

Isopentenyl pyrophosphate is a novel antinociceptive substance that inhibits TRPV3 and TRPA1 ion channels.

Bang S, Yoo S, Yang TJ, Cho H, Hwang SW.

Pain. 2011 May;152(5):1156-64. doi: 10.1016/j.pain.2011.01.044.

PMID:
21353389
9.

Novel sulfated polysaccharides disrupt cathelicidins, inhibit RAGE and reduce cutaneous inflammation in a mouse model of rosacea.

Zhang J, Xu X, Rao NV, Argyle B, McCoard L, Rusho WJ, Kennedy TP, Prestwich GD, Krueger G.

PLoS One. 2011 Feb 9;6(2):e16658. doi: 10.1371/journal.pone.0016658.

10.

The TRPV4 cation channel: A molecule linking skin temperature and barrier function.

Sokabe T, Tominaga M.

Commun Integr Biol. 2010 Nov;3(6):619-21. doi: 10.4161/cib.3.6.13461.

11.

Cerebral arteriogenesis is enhanced by pharmacological as well as fluid-shear-stress activation of the Trpv4 calcium channel.

Schierling W, Troidl K, Apfelbeck H, Troidl C, Kasprzak PM, Schaper W, Schmitz-Rixen T.

Eur J Vasc Endovasc Surg. 2011 May;41(5):589-96. doi: 10.1016/j.ejvs.2010.11.034.

12.

Functional Expression of TRPV4 Cation Channels in Human Mast Cell Line (HMC-1).

Kim KS, Shin DH, Nam JH, Park KS, Zhang YH, Kim WK, Kim SJ.

Korean J Physiol Pharmacol. 2010 Dec;14(6):419-25. doi: 10.4196/kjpp.2010.14.6.419.

13.

TRP expression pattern and the functional importance of TRPC3 in primary human T-cells.

Wenning AS, Neblung K, Strauss B, Wolfs MJ, Sappok A, Hoth M, Schwarz EC.

Biochim Biophys Acta. 2011 Mar;1813(3):412-23. doi: 10.1016/j.bbamcr.2010.12.022.

14.

TRPV channel expression in human skin and possible role in thermally induced cell death.

Radtke C, Sinis N, Sauter M, Jahn S, Kraushaar U, Guenther E, Rodemann HP, Rennekampff HO.

J Burn Care Res. 2011 Jan-Feb;32(1):150-9. doi: 10.1097/BCR.0b013e318203350c.

PMID:
21099694
15.

TRPV channels and vascular function.

Baylie RL, Brayden JE.

Acta Physiol (Oxf). 2011 Sep;203(1):99-116. doi: 10.1111/j.1748-1716.2010.02217.x. Review.

16.

Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo.

Seeliger S, Buddenkotte J, Schmidt-Choudhury A, Rosignoli C, Shpacovitch V, von Arnim U, Metze D, Rukwied R, Schmelz M, Paus R, Voegel JJ, Schmidt WE, Steinhoff M.

Am J Pathol. 2010 Nov;177(5):2563-75. doi: 10.2353/ajpath.2010.090941.

17.

Transient receptor potential vanilloid 4 activated inflammatory signals by intestinal epithelial cells and colitis in mice.

D'Aldebert E, Cenac N, Rousset P, Martin L, Rolland C, Chapman K, Selves J, Alric L, Vinel JP, Vergnolle N.

Gastroenterology. 2011 Jan;140(1):275-85. doi: 10.1053/j.gastro.2010.09.045.

PMID:
20888819
18.

Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates.

Obermoser G, Sontheimer RD, Zelger B.

Lupus. 2010 Aug;19(9):1050-70. doi: 10.1177/0961203310370048. Review.

PMID:
20693199
19.

Role of transient receptor potential vanilloid 2 in LPS-induced cytokine production in macrophages.

Yamashiro K, Sasano T, Tojo K, Namekata I, Kurokawa J, Sawada N, Suganami T, Kamei Y, Tanaka H, Tajima N, Utsunomiya K, Ogawa Y, Furukawa T.

Biochem Biophys Res Commun. 2010 Jul 23;398(2):284-9. doi: 10.1016/j.bbrc.2010.06.082. Erratum in: Biochem Biophys Res Commun. 2010 Sep 24;400(3):453.

PMID:
20599720
20.

Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group.

Elewski BE, Draelos Z, Dréno B, Jansen T, Layton A, Picardo M.

J Eur Acad Dermatol Venereol. 2011 Feb;25(2):188-200. doi: 10.1111/j.1468-3083.2010.03751.x.

PMID:
20586834
Items per page

Supplemental Content

Support Center